Does organophosphate exposure cause oxidative stress, liver injury, and adverse lipid profiles?

An evidence-based assessment of the relationships between organophosphate pesticide exposure, oxidative stress, hepatic injury, and dyslipidemia is detailed below.

Clinical and epidemiological evidence

Large-scale biomonitoring studies, including analyses of the National Health and Nutrition Examination Survey (NHANES) cohorts, consistently show that human exposure to organophosphates (OPs) is associated with systemic metabolic disruptions:

• Oxidative Stress Markers: Exposed populations and agricultural workers demonstrate elevated levels of urinary dialkylphosphate (DAP) metabolites alongside elevated lipid peroxidation markers, including malondialdehyde (MDA), F2-isoprostanes, and 4-hydroxy-2-nonenal-mercapturic acid (HNE-MA).
• Hepatic Injury: Both chronic low-dose occupational exposure and acute poisoning cohorts reveal clear signs of hepatocellular damage, marked by significant elevations in serum transaminases (alanine aminotransferase [ALT] and aspartate aminotransferase [AST]), alkaline phosphatase (ALP), and bilirubin.
• Adverse Lipid Profiles: Human epidemiological studies establish a significant correlation between OP metabolites and dyslipidemia. Exposed individuals exhibit higher circulating triglycerides (TG), altered total cholesterol, elevated low-density lipoprotein cholesterol (LDL-C), and a marked decrease in cardioprotective high-density lipoprotein cholesterol (HDL-C).

Mechanistic pathways

Toxicological and animal models confirm several overlapping pathways that link OP exposure to multi-organ dysfunction:

• Mitochondrial Dysfunction and ROS: OPs directly target mitochondria, depolarizing the mitochondrial membrane and disrupting the electron transport chain. This leads to excessive generation of reactive oxygen species (ROS), which rapidly consumes the liver's primary non-enzymatic antioxidant, glutathione (GSH).
• Impaired Hepatic Lipid Homeostasis: The liver serves as the main metabolic hub for OP bioactivation. Within hepatocytes, OPs disrupt thyroid hormone signaling and alter the transcriptional regulation of critical lipogenic genes (such as Fasn and Acc1) and peroxisome proliferator-activated receptors (PPARs), triggering abnormal lipid accumulation.
• PON1 Depletion: OPs directly bind to and consume paraoxonase-1 (PON1), a liver-synthesized enzyme that normally associates with HDL to prevent the oxidation of circulating lipoproteins. Decreased PON1 activity severely impairs HDL's antioxidant capacity and accelerates systemic cardiovascular risk.
• Cellular Injury: Cellular models show that OP-induced oxidative stress, glutathione depletion, and impaired mitophagy (mitochondrial autophagy) trigger downstream apoptotic pathways and ferroptosis, driving the structural and functional hepatic injury seen clinically.

Bottom line

Organophosphate pesticide exposure is strongly associated with systemic oxidative stress, direct hepatic injury, and adverse lipid profiles. These pathologic states are tightly linked: OP-induced mitochondrial dysfunction and ROS deplete vital antioxidant enzymes like glutathione and PON1, which in turn impairs hepatic lipid metabolism, accelerates lipid peroxidation, and causes hepatocellular damage.